Abstract
Human biomonitoring of the lipid peroxidation DNA modification 1,N6-ethenodeoxyadenosine (epsilondA) excreted into urine is thought to be a potential marker for oxidative stress-related DNA damage and human cancer. We have tested this hypothesis in a prospective, nested case-control study. During the years 1984-1989, 24-h urines were collected from 1956 men in the Kuopio Ischaemic Heart Disease (KIHD) Risk Factor Study. epsilondA concentrations were measured by LC-MS/MS in 24-h urine samples from 47 men with cancer diagnosed at follow up until 2001 and from 31 cancer free smoking-matched control subjects. Odds ratio for having higher than control median epsilon dA excretion rate and cancer, estimated by binary logistic regression, was 0.73 (95% CI 0.29-1.80, p = 0.49). In this study, the urinary excretion of epsilondA provides no additional prediction of cancer development in males after controlling for smoking.
Original language | English |
---|---|
Journal | Free Radical Research |
Volume | 39 |
Issue number | 1 |
Pages (from-to) | 51-3 |
Number of pages | 3 |
ISSN | 1071-5762 |
DOIs | |
Publication status | Published - Jan 2005 |
Keywords
- Adult
- Body Mass Index
- Body Weight
- Case-Control Studies
- Chromatography, Liquid
- DNA/metabolism
- DNA Adducts
- DNA Damage
- Deoxyadenosines/urine
- Humans
- Lipid Peroxidation
- Logistic Models
- Male
- Mass Spectrometry
- Middle Aged
- Neoplasms/diagnosis
- Odds Ratio
- Oxidative Stress
- Prospective Studies
- Risk
- Risk Factors
- Smoking
- Time Factors